Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-68238

ABSTRACT: Redefining the role of eIF4E dose in development, cancer, and protein synthesis

OTHER RELATED OMICS DATASETS IN: PRJNA282121

PROVIDER: E-GEOD-68238 | ExpressionAtlas | 2015-09-18

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-68238-analysis-methods.tsv	Tabular
	E-GEOD-68238-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-68238-configuration.xml	Xml
	E-GEOD-68238-percentile-ranks.tsv	Tabular
	E-GEOD-68238.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 124

Similar Datasets

Mus musculus

Project description:Redefining the role of eIF4E dose in development, cancer, and protein synthesis

| PRJNA282121 | ENA

Homo sapiens

Project description:Role of cohesin in cancer development

| PRJNA451395 | ENA

Redefining the role of eIF4E dose in development, cancer, and protein synthesis

Project description:eIF4E, the major cap-binding protein, has long been considered limiting for translating the mammalian genome. However, the requirement for eIF4E dose at an organismal level remains unexplored. By generating an Eif4e haploinsufficient mouse, we surprisingly found that 50% reduction in eIF4E, while compatible with normal development and global protein synthesis, significantly impeded cellular transformation and tumorigenesis. Genome-wide translational profiling uncovered a translational program induced by oncogenic transformation and revealed a critical role for eIF4E dose specifically in translating a network of mRNAs enriched for a unique 5’UTR signature. In particular, we demonstrate that eIF4E dose is essential for translating mRNAs regulating reactive oxygen species (ROS) that fuel transformation and cancer cell survival in vivo. Therefore, mammalian cells have evolved surplus eIF4E levels that cancer cells hijack to drive a translational program supporting tumorigenesis

2015-07-01 | GSE68238 | GEO

Redefining the role of eIF4E dose in development, cancer, and protein synthesis

2015-07-01 | E-GEOD-68238 | biostudies-arrayexpress

Project description:Role of microbiota in bladder cancer development

| PRJNA1119950 | ENA

Role of microbiota in bladder cancer development

Project description:Role of microbiota in bladder cancer development

| PRJEB75372 | ENA

Role of Matrix Gla Protein in Brown Adipose Tissue Development

Project description:Role of Matrix Gla Protein in Brown Adipose Tissue Development

| PRJNA975609 | ENA

Homo sapiens

Project description:Low Dose Radiation Induces New Protein Synthesis that Promotes Cancer Radiotherapy Resistance

| PRJNA1429059 | ENA

Molecular changes in cancer cells exposed to an HDAC inhibitor: A metabolomics approach

Project description:Histone deacetylase (HDAC) inhibitors are part of a new generation of epigenetic drugs for cancer treatment. It is known that histone acetylation plays a key role in controlling essential chromosome functions, including gene regulation, and this process has been linked with cancer development and progression. Better understanding of molecular mechanisms involving HDAC inhibitors is needed for the design of new targeted drugs, and also to evaluate the effectiveness of current treatments. In this study, an untargeted metabolomics approach was used to identify intracellular metabolite deregulation after treating cancer cell lines with the HDAC inhibitor HC-Toxin. Metabolomics analysis was performed using high resolution mass spectrometry, in combination with univariate and multivariate statistics and pathway analysis. HDAC inhibition showed highly specific metabolic changes in cancer cell lines compared to non-cancerous cells. In particular, N-acetyl-L-cysteine, N-acetylmethionine, and N-acetyl-L-carnitine showed a dose dependent change. Moreover, pathways controlling protein biosynthesis, as well as tryptophan, cysteine and methionine metabolism were significantly altered by HDAC inhibition. This study illustrates that HDAC inhibition has multiple effects on different metabolic pathways and our results can be extrapolated to inform on the molecular transitions in human cells.

2022-05-04 | MTBLS682 | MetaboLights

Homo sapiens

Project description:Patterns of cancer development and progression in the protein-protein interaction network

| PRJNA144777 | ENA